Skip to content
New: 100+ more US companies, including the big banks, plus insider trades from SEC filings

Compare · Health Care

Cigna vs. CVS Health: how they make money

The same facts for both companies, in the same order, from each company's own page and filings. It is not a ranking.

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

How they differ

In FY2025, CVS Health's revenue of $402.1B was about 1.5 times Cigna's $274.9B (Cityfort calculation: one divided by the other).

Cigna's largest segment is Evernorth Health Services, 83.1% of revenue in FY2025; CVS Health's largest segment is Health Services, 40.2% of revenue in FY2025.

United States brought in 98.0% of Cigna's revenue in FY2025.

Cigna's largest payer group is Buyers of drugs and pharmacy services, 78.8% of revenue (FY2025); CVS Health's largest payer group is Buyers of products, 62.2% of revenue (FY2025).

Cigna's page lists CVS Health among its competitors; CVS Health's page does not list Cigna.

Sources: Cigna S1 · CVS Health S1

Each company in 5 points

Cigna

  1. 1 · What it sells

    The Cigna Group runs drug benefits and pharmacies through Evernorth, including Express Scripts, and health plans for 18.1 million medical customers through Cigna Healthcare, with total revenues of $274.9 billion in FY2025.

    Sources and detail on the Cigna page
  2. 2 · Who pays it

    In FY2025, health plans, employers and government programs paid 78.8% of revenue for drugs and pharmacy services, insurance premiums brought 14.6%, fees for services 6.2%, and investment income added 0.4%.

    Sources and detail on the Cigna page
  3. 3 · What it keeps from $100

    Of every $100 that came in during FY2025, Cigna kept $2.17 as net income, after a $749 million strategic optimization charge and with a $401 million after-tax gain on its Medicare sale, while income from operations was $3.35 per $100 of revenue.

    Sources and detail on the Cigna page
  4. 4 · Where the operating profit comes from

    FY2025 income before taxes was $5.83 billion in Evernorth Health Services and $4.34 billion in Cigna Healthcare, against a $46 million loss in Other Operations and $2.34 billion of corporate costs and eliminations.

    Sources and detail on the Cigna page
  5. 5 · The one thing to watch

    One drug-benefit client that the 10-K does not name brought about 19% of FY2025 revenue, and Cigna said in its FY2025 10-K (Feb 26, 2026) that its rebate-free model becomes standard for Evernorth's drug-benefit clients from 2028.

    Sources and detail on the Cigna page

CVS Health

  1. 1 · What it sells

    CVS Health sells health insurance through Aetna, runs drug benefits through CVS Caremark and fills prescriptions in about 9,000 retail locations, with total revenues of $402.1 billion in FY2025.

    Sources and detail on the CVS Health page
  2. 2 · Who pays it

    In FY2025, buyers of products such as health plans, employers, government programs and shoppers paid 62.2% of revenue, government insurance programs 25.7%, commercial insurance customers 7.8%, service clients 3.8%, and investment income added 0.6%.

    Sources and detail on the CVS Health page
  3. 3 · What it keeps from $100

    Of every $100 that came in during FY2025, CVS Health kept $0.44 as net income, which includes large one-off items in both directions; operating income per $100 of total revenues was $1.16 as reported and $3.59 on its adjusted measure.

    Sources and detail on the CVS Health page
  4. 4 · Where the operating profit comes from

    FY2025 operating income was $4.86 billion in Pharmacy & Consumer Wellness, $1.79 billion in Health Care Benefits and $220 million in Health Services after a $5.7 billion goodwill impairment, with a $2.21 billion Corporate/Other loss.

    Sources and detail on the CVS Health page
  5. 5 · The one thing to watch

    Members in Medicare Advantage plans rated 4 stars or higher went from 88% in the 2025 ratings to more than 69% in the 2027 ratings, which set 2028 bonus payments, and Aetna's president named 2028 for target margins on May 6, 2026.

    Sources and detail on the CVS Health page

Where each $100 went

Each company's own receipt for its latest full fiscal year, with matching lines in the same order where both have them.

Cigna

Where $100 went · FY2025

Where $100 of Cigna's money went in FY2025
Buying drugs and paying pharmacies$78.2
Medical claims$12.5
Selling, general and administrative$5.3
Amortization of acquired intangibles$0.6
Interest, investment losses and other$0.5
Income tax and minority owners' share$0.7
Kept as net income$2.2
Total$100

Cityfort calculation from the FY2025 10-K. Of every $100 that came in during FY2025 (total revenues plus a $13 million gain on business sales): each line = line ÷ $274.9 billion × 100. Income from operations was $3.35 per $100 of total revenues.

CVS Health

Where $100 went · FY2025

Where $100 of CVS Health's money went in FY2025
Cost of products sold$54.9
Health care costs (medical claims)$31.2
Operating expenses$11.2
Goodwill impairment (one-off, non-cash)$1.4
Interest$0.8
Income tax$0.1
Kept as net income$0.4
Total$100

Cityfort calculation from FY2025 10-K. Of every $100 that came in during FY2025 (total revenues plus $595 million of deconsolidation gain and other income): each line = line ÷ $402.7 billion × 100. Net income attributable to CVS Health was $0.44. Operating income was $1.16 per $100 of total revenues, after the $5.7 billion impairment. It was $3.58 per $100 in the 12 months to Sep 30, 2026, which leave that charge out (Cityfort calculation from FY2025 10-K and Q3 FY2026 earnings release).

Line items differ because each company groups its costs its own way in its filings. Only on Cigna's receipt: Buying drugs and paying pharmacies; Medical claims; Selling, general and administrative; Amortization of acquired intangibles; Interest, investment losses and other; Income tax and minority owners' share. Only on CVS Health's receipt: Cost of products sold; Health care costs (medical claims); Operating expenses; Goodwill impairment (one-off, non-cash); Interest; Income tax.

Sources: Cigna S1 · CVS Health S1

Revenue, net income and free cash flow

Up to five fiscal years for each company, drawn on one shared scale per measure. Amounts in US$ as reported (GAAP).

Revenue

Cigna

CVS Health

Both charts use the same scale. Each company's own fiscal years.
See the numbers
Revenue of Cigna and CVS Health by fiscal year, US$
Cigna yearCigna revenueCVS Health yearCVS Health revenue
FY2021$174.1BFY2021$292.1B
FY2022$180.5BFY2022$322.5B
FY2023$195.3BFY2023$357.8B
FY2024$247.1BFY2024$372.8B
FY2025$274.9BFY2025$402.1B

Net income

Cigna

CVS Health

Both charts use the same scale. Each company's own fiscal years.
See the numbers
Net income of Cigna and CVS Health by fiscal year, US$
Cigna yearCigna net incomeCVS Health yearCVS Health net income
FY2021$5.4BFY2021$8.0B
FY2022$6.7BFY2022$4.3B
FY2023$5.2BFY2023$8.3B
FY2024$3.4BFY2024$4.6B
FY2025$6.0BFY2025$1.8B

Free cash flow

Cigna

CVS Health

Both charts use the same scale. Each company's own fiscal years; free cash flow = cash from operations minus capital spending, as on each company's page.
See the numbers
Free cash flow of Cigna and CVS Health by fiscal year, US$
Cigna yearCigna free cash flowCVS Health yearCVS Health free cash flow
FY2021$6.0BFY2021$15.7B
FY2022$7.4BFY2022$13.5B
FY2023$10.2BFY2023$10.4B
FY2024$9.0BFY2024$6.3B
FY2025$8.4BFY2025$7.8B

Sources: Cigna S3, S1 · CVS Health S3, S1

Growth and net margin, FY2021 to FY2025

Worked out over the years both pages cover, so the two growth figures use the same span. Net margin is net income as a share of revenue, as on each page.

Cigna

Revenue, per year
+12.1%
Net income, per year
+2.6%

CVS Health

Revenue, per year
+8.3%
Net income, per year
−31.4%

Cityfort calculation: compound growth per year from FY2021 to FY2025 (4 years), from each page's yearly numbers, as reported.

Net margin by year
Net margin (net income as a share of revenue) of Cigna and CVS Health by fiscal year, as on each page
YearCignaCVS Health
FY20213.1%2.7%
FY20223.7%1.3%
FY20232.6%2.3%
FY20241.4%1.2%
FY20252.2%0.4%

Sources: Cigna S3, S1 · CVS Health S3, S1

Latest quarter, against the same quarter a year earlier

Each page's latest quarter as reported; the change is a Cityfort calculation.

Cigna

Q3 FY2026, the quarter to Sep 30, 2026, against Q3 FY2025

Cigna, Q3 FY2026 against Q3 FY2025
MeasureQ3 FY2026Q3 FY2025Change
Revenue$73.7B$69.7B+5.6%
Net income$1.4B$1.9B−22.8%

CVS Health

Q3 FY2026, the quarter to Sep 30, 2026, against Q3 FY2025

CVS Health, Q3 FY2026 against Q3 FY2025
MeasureQ3 FY2026Q3 FY2025Change
Revenue$108.4B$102.9B+5.4%
Net income$2.2B−$4.0B–

Sources: Cigna S5, S8, S12, S1, S7, S6, S9 · CVS Health S13, S12, S11, S10, S9

Who pays each company

Cigna

  • Buyers of drugs and pharmacy services · 78.8% of revenueHealth plans, employers and government programs pay for prescriptions filled through Cigna's networks, home delivery and specialty pharmacy: $216.7 billion, 78.8% of FY2025 total revenues (Cityfort calculation from the FY2025 10-K).
  • Insurance premiums · 14.6% of revenueEmployers and individuals pay premiums for insured plans, large-claim cover for self-funded employers and international health cover: $40.3 billion, 14.6% of total revenues.
  • Fees for services · 6.2% of revenueFees and other revenues, from Evernorth services and from running plans that employers fund themselves: $16.9 billion, 6.2% of total revenues.
  • Investment income · 0.4% of revenueNot a customer: net investment income of $1.0 billion, 0.4% of total revenues.

CVS Health

  • Buyers of products · 62.2% of revenueHealth plans, drug-benefit managers, employers, government programs and shoppers pay for drugs and store goods: $249.9 billion, 62.2% of FY2025 total revenues.
  • Government insurance programs · 25.7% of revenuePremiums from government business such as Medicare and Medicaid: $103.4 billion, 25.7% of total revenues (Cityfort calculation from FY2025 10-K).
  • Commercial insurance customers · 7.8% of revenuePremiums from commercial plans: $31.4 billion, 7.8% of total revenues (Cityfort calculation from FY2025 10-K).
  • Service clients · 3.8% of revenueFees for services, for example from employers and plans: $15.2 billion, 3.8% of total revenues.
  • Investment income · 0.6% of revenueNot a customer: net investment income of $2.2 billion, 0.6% of total revenues.

Sources: Cigna S1 · CVS Health S1

Revenue by segment

Cigna

FY2025

Cigna revenue by segment, FY2025
SegmentRevenueShare
Evernorth Health Services$235.0B83.1%
Cigna Healthcare$47.2B16.7%
Other Operations$674M0.2%

CVS Health

FY2025

CVS Health revenue by segment, FY2025
SegmentRevenueShare
Health Services$190.4B40.2%
Health Care Benefits$143.4B30.3%
Pharmacy & Consumer Wellness$139.4B29.4%
Corporate/Other$484M0.1%

Sources: Cigna S1 · CVS Health S1

Where the revenue comes from

Revenue by region, as each company splits it, with the period.

Cigna

FY2025

  • United States98.0%
  • Outside the United States2.0%

CVS Health

Not on the CVS Health page.

Sources: Cigna S1

Debt and cash

Cigna

Debt
$31.1B
Cash and investments
$6.2B

On Sep 30, 2026.

At Sep 30, 2026, Cigna's debt exceeded its cash by $25.0 billion (Cityfort calculation from the Q3 FY2026 10-Q). That is about 2.6 times FY2025 cash from operations of $9.6 billion (Cityfort calculation from the Q3 FY2026 10-Q and FY2025 10-K).

CVS Health

Debt
$60.7B
Cash and investments
$11.7B

On Sep 30, 2026.

At Sep 30, 2026, CVS Health's debt exceeded its cash by $48.9 billion. That is about 2.6 times the $18.7 billion of cash from operations in the prior four quarters (Cityfort calculation from FY2025 10-K and Q3 FY2026 earnings release). Cash from operations rose $8.1 billion in the first nine months of 2026 from a year earlier. The company says that was primarily due to timing of receipts and payments and Health Care Benefits performance.

Sources: Cigna S1, S5, S9 · CVS Health S1, S6, S9

Who owns each company

Cigna

  • One class of shares.
  • Officers and directors as a group: 0.6% of shares (as of Jan 30, 2026).
  • Vanguard Capital Management LLC: 7.5% (as of Apr 29, 2026).
  • BlackRock, Inc.: 7.6% (as of Apr 24, 2025).

CVS Health

  • One class of shares.
  • Officers and directors as a group: 0.7% of shares (as of Mar 16, 2026).
  • BlackRock, Inc.: 8.3% (as of Jul 16, 2025).
  • Vanguard Capital Management LLC: 7.5% (as of Mar 31, 2026).
  • Capital World Investors: 5.5% (as of May 13, 2025).
  • 1 more holders on the CVS Health page.

Sources: Cigna S14, S5, S15, S16 · CVS Health S8, S24, S33, S34

What protects each business

What each page lists as protecting the business from competitors, each with its written reason. These describe business traits, not the share.

Cigna

  • Scale in drug benefits

    Evernorth handled 2,222 million pharmacy claims in FY2025, up from 1,585 million in FY2023, and had 123.6 million pharmacy customers at Dec 31, 2025.

  • Long contracts with large clients

    Cigna says contracts with its three largest clients run through the end of the decade. But one client alone brought about 19% of FY2025 revenue.

  • Plans run for self-funded employers

    14.3 million of 18.1 million medical customers were in employer-funded plans, where the employer pays the claims and Cigna earns fees for running the plan.

CVS Health

  • Scale in drug benefits

    CVS Caremark had about 87 million plan members and processed 1.9 billion claims in FY2025. An FTC complaint places CVS subsidiaries among the three largest drug-benefit managers.

  • Pharmacy reach

    About 9,000 retail locations filled 1.8 billion prescriptions in FY2025 (30-day equivalent), up from 1.6 billion in FY2023.

  • Owning insurer, drug-benefit manager and pharmacy

    The segments did $71.6 billion of business with each other in FY2025. Some states have enacted or are considering laws barring drug-benefit managers' affiliates from pharmacy licenses, and the company now plans to split.

  • Medicare quality ratings

    More than 69% of Medicare Advantage members were in plans rated 4 stars or higher for 2027, down from more than 81% for 2026.

Sources: Cigna S1, S9, S24 · CVS Health S1, S6, S12, S19

Where growth could come from

Each page's growth drivers. The status compares progress with what the company itself said it would do; it is not a view on the share.

Cigna

  • Specialty and Care Services · Working: on track against what the company said$102.8B adjusted revenues, FY2025
  • Pharmacy Benefit Services · Mixed: partly on track$765M pre-tax adjusted income, Q3 FY2026
  • Cigna Healthcare after the Medicare sale · Working: on track against what the company said18.5 million medical customers, Sep 30, 2026
  • Rebate-free drug pricing · New: recently announcedPlanned standard for Evernorth clients from 2028
  • Cost programs · Early: too early to judge$3 billion Accelerate to One initiative

CVS Health

  • Aetna's medical costs · Working: on track against what the company saidMedical benefit ratio 91.3%, Q3 FY2026
  • Medicare star ratings · Behind: behind the company's own planMore than 69%, 2027 ratings
  • Mail and specialty pharmacy · Working: on track against what the company said$79.3B, FY2025
  • Prescriptions at the pharmacy · Mixed: partly on trackPrescription volume +3.9%, Q3 FY2026
  • Oak Street Health and clinics · Mixed: partly on track$5.7B goodwill impairment, Q3 FY2025
  • Split into two companies · New: recently announcedExpected first half of 2028

Sources: Cigna S1, S9, S5, S18 · CVS Health S1, S9, S36, S6, S23, S38, S19, S20, S22

Dividends, buybacks, auditor and credit rating

Dividends per share and buybacks for up to five years, the independent auditor and the latest credit rating, as each page records them.

Cigna

  • Dividends per shareFY2021: $4.00 · FY2022: $4.48 · FY2023: $4.92 · FY2024: $5.60 · FY2025: $6.04
  • Buybacks
    • Dec 31, 2022: FY2022: paid $7.6 billion for its own shares. ($7.6B)
    • Dec 31, 2023: FY2023: paid $2.3 billion for its own shares. ($2.3B)
    • Dec 31, 2024: FY2024: paid $7.0 billion for 20.9 million shares. ($7.0B)
    • Dec 31, 2025: FY2025: paid $3.6 billion for 11.9 million shares. ($3.6B)
  • AuditorPricewaterhouseCoopers LLP, since 1983
  • Credit ratingMoody's, S&P Global Ratings and Fitch (as stated in Cigna's Sep 3, 2025 bond pricing term sheet): Baa1 / A- / BBB+, outlook Stable (all three) (Sep 3, 2025)

CVS Health

  • Dividends per shareFY2021: $2.00 · FY2022: $2.20 · FY2023: $2.42 · FY2024: $2.66 · FY2025: $2.66
  • Buybacks
    • Dec 31, 2022: FY2022: paid $3.5 billion for its own shares. FY2021 had none. ($3.5B)
    • Dec 31, 2023: FY2023: paid $2.0 billion for its own shares. ($2.0B)
    • Dec 31, 2024: FY2024: paid $3.0 billion for its own shares. FY2025 had none. ($3.0B)
  • AuditorErnst & Young LLP
  • Credit ratingFitch, Moody's and S&P (as stated by CVS Health): BBB / Baa3 / BBB, outlook Negative (Fitch), positive (Moody's), stable (S&P) (Sep 30, 2026)

Sources: Cigna S3, S1, S20 · CVS Health S3, S1, S8, S6

Risks only one page tracks

Risks whose type the other company's page does not list. Both pages track risks of these types: regulation, pricing, debt, legal cases, execution. Every risk is on each company's page.

Cigna

  • A few very large drug-benefit clients (customer or supplier concentration)One client, not named in the 10-K, brought about 19% of FY2025 revenue, up from 16% in FY2024. Pharmacy customers fell from 123.6 million at Dec 31, 2025 to 117.7 million at Sep 30, 2026, which the company says reflects expected client transitions and lower membership from health plan clients.
  • Investment write-downs (other)FY2024 net income carried about $2.7 billion of losses from writing off the VillageMD investment. In Q3 2025, Cigna put $3.5 billion into Shields Health Solutions preferred stock.

CVS Health

  • More goodwill charges (other)Goodwill was $85.5 billion at Sep 30, 2026, 33% of total assets. After the $5.7 billion charge, Health Care Delivery's fair value exceeded its carrying value by only about 3% at the Q4 2025 test.

Sources: Cigna S1, S9 · CVS Health S1, S9

Key facts

How does Cigna make money compared with CVS Health?
Cigna's revenue by segment in FY2025: Evernorth Health Services 83.1%, Cigna Healthcare 16.7%, Other Operations 0.2%. CVS Health's revenue by segment in FY2025: Health Services 40.2%, Health Care Benefits 30.3%, Pharmacy & Consumer Wellness 29.4%, Corporate/Other 0.1%.
Which is bigger by revenue, Cigna or CVS Health?
Cigna reported $274.9B of revenue in FY2025, and CVS Health reported $402.1B in FY2025.
How much net income did Cigna and CVS Health report?
Cigna reported net income of $6.0B in FY2025, and CVS Health reported $1.8B in FY2025.
How much of every $100 did Cigna and CVS Health keep as net income?
Cigna kept $2.2 of every $100 that came in during FY2025, and CVS Health kept $0.4 in FY2025 (Cityfort calculation from each company's annual report).
How much debt and cash do Cigna and CVS Health have?
Cigna had $31.1B of debt and $6.2B of cash and investments on Sep 30, 2026. CVS Health had $60.7B of debt and $11.7B of cash and investments on Sep 30, 2026.
When do Cigna's and CVS Health's fiscal years end?
Cigna: December 31. CVS Health: December 31.

Sources: Cigna S3, S1, S5, S9 · CVS Health S3, S1, S6, S9

Built from each company's page. Cigna updated Nov 6, 2026; CVS Health updated Nov 6, 2026.

Sources

Cigna

  1. S1Form 10-K, fiscal year 2025 (ended Dec 31, 2025), The Cigna Group (SEC EDGAR), Feb 26, 2026
  2. S3Form 10-K, fiscal year 2023 (ended Dec 31, 2023), The Cigna Group (SEC EDGAR), Feb 29, 2024
  3. S5Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026), The Cigna Group (SEC EDGAR), Nov 5, 2026
  4. S6Form 10-Q, Q2 FY2026 (quarter ended Jun 30, 2026), The Cigna Group (SEC EDGAR), Jul 30, 2026
  5. S7Form 10-Q, Q1 FY2026 (quarter ended Mar 31, 2026), The Cigna Group (SEC EDGAR), Apr 30, 2026
  6. S8Form 10-Q, Q3 FY2025 (quarter ended Sep 30, 2025), The Cigna Group (SEC EDGAR), Oct 30, 2025
  7. S9Q3 2026 earnings release (Form 8-K, Exhibit 99.1), The Cigna Group (SEC EDGAR), Nov 5, 2026
  8. S12Q4 and full-year 2025 earnings release (Form 8-K, Exhibit 99.1), The Cigna Group (SEC EDGAR), Feb 5, 2026
  9. S142026 proxy statement (DEF 14A), The Cigna Group (SEC EDGAR), Mar 13, 2026
  10. S15Schedule 13G/A filed by The Vanguard Group (0 shares after Jan 12, 2026 realignment), The Vanguard Group (SEC EDGAR), Mar 26, 2026
  11. S16Schedule 13G filed by Vanguard Capital Management LLC (7.51% as of Mar 31, 2026), Vanguard Capital Management LLC (SEC EDGAR), Apr 29, 2026
  12. S18Form 8-K filed Sep 30, 2026 (Investor Day, 2030 targets; Exhibit 99.1), The Cigna Group (SEC EDGAR), Sep 30, 2026
  13. S20Free writing prospectus (pricing term sheet, senior notes) filed Sep 3, 2025: issuer ratings, The Cigna Group (SEC EDGAR), Sep 3, 2025
  14. S24CVS Health Form 10-K, fiscal year 2025 (ended Dec 31, 2025), CVS Health Corporation (SEC EDGAR), Feb 10, 2026

CVS Health

  1. S1Form 10-K, fiscal year 2025 (ended Dec 31, 2025), CVS Health Corporation (SEC EDGAR), Feb 10, 2026
  2. S3Form 10-K, fiscal year 2023 (ended Dec 31, 2023), CVS Health Corporation (SEC EDGAR), Feb 7, 2024
  3. S6Form 10-Q, Q3 FY2026 (ended Sep 30, 2026), CVS Health Corporation (SEC EDGAR), Nov 4, 2026
  4. S8Proxy statement (DEF 14A) for the 2026 annual meeting, CVS Health Corporation (SEC EDGAR), Apr 3, 2026
  5. S9Q3 2026 earnings release (8-K Ex. 99.1), CVS Health Corporation (SEC EDGAR), Nov 4, 2026
  6. S10Q2 2026 earnings release (8-K Ex. 99.1), CVS Health Corporation (SEC EDGAR), Aug 5, 2026
  7. S11Q1 2026 earnings release (8-K Ex. 99.1), CVS Health Corporation (SEC EDGAR), May 6, 2026
  8. S12Q4 and full-year 2025 earnings release (8-K Ex. 99.1), CVS Health Corporation (SEC EDGAR), Feb 10, 2026
  9. S13Q3 2025 earnings release (8-K Ex. 99.1), CVS Health Corporation (SEC EDGAR), Oct 29, 2025
  10. S198-K (Item 7.01) press release: intent to separate into two companies, CVS Health Corporation (SEC EDGAR), Nov 4, 2026
  11. S20Investor Update presentation: "Creating two distinct leaders in healthcare", CVS Health Corporation (investor relations), Nov 4, 2026
  12. S222026 Consolidated Guidance Summary (Q3 2026 call), CVS Health Corporation (investor relations), Nov 4, 2026
  13. S238-K Ex. 99.1: 2025 Investor Day release, guidance and growth rate through 2028, CVS Health Corporation (SEC EDGAR), Dec 9, 2025
  14. S248-K (Item 5.02): Robbins resignation, Heitsenrether appointment, CVS Health Corporation (SEC EDGAR), Aug 17, 2026
  15. S33Schedule 13G, Vanguard Capital Management, Vanguard Capital Management (SEC EDGAR), Apr 29, 2026
  16. S34Schedule 13G/A, The Vanguard Group, The Vanguard Group (SEC EDGAR), Mar 26, 2026
  17. S36Q1 2026 earnings call transcript, CVS Health Corporation (investor relations), May 6, 2026
  18. S38Q3 2025 earnings call transcript, CVS Health Corporation (investor relations), Oct 29, 2025

Disclaimer

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.

Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.

Read the positions policy
Read the full disclaimer

Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.

All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.

Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.